Clinical Trial Update: Brief Behavioral Activation Intervention for Depressed Asthma and Urticaria Patients [NA]

View source ↗

Summary

The clinical trial assessing a Brief Behavioral Activation Intervention for patients with depression and comorbid asthma and urticaria has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Major Depressive Disorder
• Urticaria

Snippet

Sponsor: University of Mississippi Medical Center | Conditions: Depression, Asthma | NA | Status: TERMINATED